Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
Klein S, Pekosz A, Park HS, Ursin R, Shapiro J, Benner S, Littlefield K, Kumar S, Naik HM, Betenbaugh M, Shrestha R, Wu A, Hughes R, Burgess I, Caturegli P, Laeyendecker O, Quinn T, Sullivan D, Shoham S, Redd A, Bloch E, Casadevall A, Tobian A. Klein S, et al. Among authors: laeyendecker o. medRxiv [Preprint]. 2020 Jun 28:2020.06.26.20139063. doi: 10.1101/2020.06.26.20139063. medRxiv. 2020. PMID: 32607519 Free PMC article. Updated. Preprint.
Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection.
Patel EU, Cox AL, Mehta SH, Boon D, Mullis CE, Astemborski J, Osburn WO, Quinn J, Redd AD, Kirk GD, Thomas DL, Quinn TC, Laeyendecker O. Patel EU, et al. Among authors: laeyendecker o. J Infect Dis. 2016 Aug 1;214(3):344-52. doi: 10.1093/infdis/jiw005. Epub 2016 Jan 14. J Infect Dis. 2016. PMID: 26768250 Free PMC article.
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva.
Randad PR, Pisanic N, Kruczynski K, Manabe YC, Thomas D, Pekosz A, Klein SL, Betenbaugh MJ, Clarke WA, Laeyendecker O, Caturegli PP, Larman HB, Detrick B, Fairley JK, Sherman AC, Rouphael N, Edupuganti S, Granger DA, Granger SW, Collins M, Heaney CD. Randad PR, et al. Among authors: laeyendecker o. medRxiv [Preprint]. 2020 May 26:2020.05.24.20112300. doi: 10.1101/2020.05.24.20112300. medRxiv. 2020. PMID: 32511537 Free PMC article. Updated. Preprint.
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
Klein SL, Pekosz A, Park HS, Ursin RL, Shapiro JR, Benner SE, Littlefield K, Kumar S, Naik HM, Betenbaugh MJ, Shrestha R, Wu AA, Hughes RM, Burgess I, Caturegli P, Laeyendecker O, Quinn TC, Sullivan D, Shoham S, Redd AD, Bloch EM, Casadevall A, Tobian AA. Klein SL, et al. Among authors: laeyendecker o. J Clin Invest. 2020 Nov 2;130(11):6141-6150. doi: 10.1172/JCI142004. J Clin Invest. 2020. PMID: 32764200 Free PMC article.
Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point of Care Testing.
Conklin SE, Martin K, Manabe YC, Schmidt HA, Keruly M, Klock E, Kirby CS, Baker OR, Fernandez RE, Eby YJ, Hardick J, Shaw-Saliba K, Rothman RE, Caturegli PP, Redd AR, Tobian AA, Bloch EM, Larman HB, Quinn TC, Clarke W, Laeyendecker O. Conklin SE, et al. Among authors: laeyendecker o. medRxiv [Preprint]. 2020 Aug 4:2020.07.31.20166041. doi: 10.1101/2020.07.31.20166041. medRxiv. 2020. PMID: 32793916 Free PMC article. Updated. Preprint.
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers.
Patel EU, Bloch EM, Clarke W, Hsieh YH, Boon D, Eby Y, Fernandez RE, Baker OR, Keruly M, Kirby CS, Klock E, Littlefield K, Miller J, Schmidt HA, Sullivan P, Piwowar-Manning E, Shrestha R, Redd AD, Rothman RE, Sullivan D, Shoham S, Casadevall A, Quinn TC, Pekosz A, Tobian AAR, Laeyendecker O. Patel EU, et al. Among authors: laeyendecker o. medRxiv [Preprint]. 2020 Sep 2:2020.08.31.20184788. doi: 10.1101/2020.08.31.20184788. medRxiv. 2020. PMID: 32908987 Free PMC article. Updated. Preprint.
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
Benner SE, Patel EU, Laeyendecker O, Pekosz A, Littlefield K, Eby Y, Fernandez RE, Miller J, Kirby CS, Keruly M, Klock E, Baker OR, Schmidt HA, Shrestha R, Burgess I, Bonny TS, Clarke W, Caturegli P, Sullivan D, Shoham S, Quinn TC, Bloch EM, Casadevall A, Tobian AAR, Redd AD. Benner SE, et al. Among authors: laeyendecker o. J Infect Dis. 2020 Nov 13;222(12):1974-1984. doi: 10.1093/infdis/jiaa581. J Infect Dis. 2020. PMID: 32910175 Free PMC article.
SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy.
Natarajan H, Crowley AR, Butler SE, Xu S, Weiner JA, Bloch EM, Littlefield K, Wieland-Alter W, Connor RI, Wright PF, Benner SE, Bonny TS, Laeyendecker O, Sullivan D, Shoham S, Quinn TC, Larman HB, Casadevall A, Pekosz A, Redd AD, Tobian AAR, Ackerman ME. Natarajan H, et al. Among authors: laeyendecker o. medRxiv [Preprint]. 2020 Sep 18:2020.09.16.20196154. doi: 10.1101/2020.09.16.20196154. medRxiv. 2020. PMID: 32995801 Free PMC article. Updated. Preprint.
312 results